$3.78
▲ $0.01 (+0.3%)
SABS
SAB Biotherapeutics, Inc. - Common Stock
Health Care
Investor Score
54C-
Moderate rating
Based on 7 of 7 weighted categories, computed from real, live financial data only.
71
Technical
54
Fundamental
54
Growth
38
Fair Value
50
News
42
Quality
48
Risk
Want the full breakdown — DCF fair value, technical indicators, news sentiment, and an AI-written narrative explaining this score?
View the full analysis (Hebrew) ←All raw data comes from real commercial financial data providers. This page is for educational purposes only and is not investment advice.